000			03131nam a2200277 4500
001			384276
010			_a9291680567
090			_a384276
100			_a20070514d2001 y0pory50 ba
101			_aeng
200			_aModelling drug use _emethods to quantify and understand hidden processes _fEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA
210			_aLuxembourg _cOffice for Official Publications of the European Communities _d2001
215			_a245 p. _d24 cm
225			_aEMCDDA Scientific Monograph Series _v6
330			_aForeword (Georges Estievenart). General introduction (Lucas Wiessing; Richard Hartnoll). Part I - What is modelling and how can it be used?: Introduction. Chapter 1 - Epidemiology of drug use at macro level: indicators, models and policy-making (Lucas Wiessing, Richard Hartnoll; Carla Rossi). Chapter 2 - What are dynamic models and how can they be used? (Christine Godfrey; Steve Parrot; Mathew Sutton; Vanessa Waby; Philip Young and Catherine Comiskey; Martin Frischer; Gordon Hay; Mathew Hickman; Johannes Jager; James Kahan; Ludwig Kraus; Roberto Mollica; Maarten Postma; Roland Simon; Colin Tayçor; Lucas Wiessing). Part II - Modelling drug use with available data: Introduction. Chapter 3 - Modelling drug misuse in Europe using geographic information systems (Martin Frischer; Heath Heatlie). Chapter 4 - Using available data with dynamic models to estimate the extent of problem drug use (Carla Rossi). Chapter 5 - Multiple-indicator models (Roberto Mollica and Fabio Mariani). Part III - Modelling techniques and their uses: Introduction. Chapter 6 - The method of back calculation as a means of estimating incidence (Catherine Comiskey; Gordon Hay). Chapter 7 - Compartment modelling and stochastic dynamic systems (Gordon Hay; Catherine Comiskey). Chapter 8 - Dynamic models in drug epidemiology (Colin Taylor; Philip Young). Chapter 9 - Structural equations and path analyses: using multiple indicators of drug prevalence (Colin Taylor; Philip Young). Part IV - Modelling the health consequences of drug use: Introduction. Chapter 10 - Modelling infectious diseases and other health consequences: predicting future morbidity consequences and spread of HIV, hepatitis B and hepatitis C. (Mirjam Kretzschmar). Chapter 11 - Developing multinational scenario analyses of health impacts of drug use (Johanes C. Jager; Maarten J. Postma; Peter W. Achterberg). Part V - Economic Models: Introduction. Chapter 12 - Modelling the health-care costs of drug-use-related disease (Maarten J. Postma; Keith Tolley; Johannes C. Jager). Chapter 13 – Economic market models (Matthew Sutton). General conclusions (Richard Hartnoll; Lucas Wiessing). Contributors.
606			_aDROGA _9228142
606			_aPREVENÇÃO DA TOXICODEPENDÊNCIA _9103892
606			_aMETODOLOGIAS _9341295
606			_aESTATÍSTICAS SOBRE DROGA _9344136
606			_aOEDT _9321506
606			_aUNIÃO EUROPEIA _9224774
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987
955			_xOferta